BioGPS
  • Home
  • Help
  • Plugins
  • Datasets
  • Sign Up
  • Login
Examples: Gene Symbol(s), Gene Ontology, Splicing plugins, Melanoma datasets
advanced
Home › Dataset Library › Genomic Grade Index (GGI): Feasibility in routine practice and impact on treatment decisions in early breast cancer

Dataset: Genomic Grade Index (GGI): Feasibility in routine practice and impact on treatment decisions in early breast cancer

Genomic Grade Index (GGI) is a 97-gene signature that improves histologic grade (HG) classification in invasive breast carcinoma. In this...

Registered by ArrayExpress Uploader
View Dataset

Genomic Grade Index (GGI) is a 97-gene signature that improves histologic grade (HG) classification in invasive breast carcinoma. In this prospective study we sought to evaluate the feasibility of performing GGI in routine clinical practice and its impact on treatment recommendations. Patients with pT1pT2 or operable pT3, N0-3 invasive breast carcinoma were recruited from 8 centers in Belgium. Fresh surgical samples were sent at room temperature in the MapQuant Dx™ PathKit for centralized genomic analysis. Genomic profiles were determined using Affymetrix U133 Plus 2.0 and GGI calculated using the MapQuant Dx™ protocol, which defines tumors as low or high Genomic Grade (GG-1 and GG-3 respectively). 180 pts were recruited and 155 were eligible. The MapQuant test was performed in 142 cases and GGI was obtained in 78% of cases (n=111). Reasons for failures were 15 samples with <30% of invasive tumor cells (11%), 15 with insufficient RNA quality (10%), and 1 failed hybridization (<1%). For tumors with an available representative sample (≥ 30% inv. tumor cells) (n=127), the success rate was 87.5 %. GGI reclassified 69% of the 54 HG2 tumors as GG-1 (54%) or GG-3 (46%). Changes in treatment recommendations occurred mainly in the subset of HG2 tumors reclassified into GG-3, with increased use of chemotherapy in this subset. The use of GGI is feasible in routine clinical practice and impacts treatment decisions in early-stage breast cancer. Total RNA was extracted from fresh tumor tissues comprising ≥30% invasive tumor cells and hybridized on Affymetrix microarrays if the RIN was ≥ 7.

Species:
human

Samples:
111

Source:
E-GEOD-43365

Updated:
Dec.12, 2014

Registered:
Jul.12, 2014


Factors: (via ArrayExpress)
Sample PR HIST CENTRE GG GRADE HISTO AGE MENOP COMORB SIZE MM HER2 NODES GGI ER
GSM1061142 1 lobular 1 equivocal 2 80 postmenopausal average for age 15 0 0 -0.3 1
GSM106114 1 ductal 1 equivocal 1 75 postmenopausal minor 10 0 0 0.2 1
GSM1061140 0 ductal 1 3 3 42 premenopausal minor 17 0 0 2 1
GSM1061139 1 ductal 1 1 1 51 postmenopausal minor 11 0 0 -1.5 1
GSM1061138 1 ductal 1 3 3 41 NA minor 16 1 0 0.6 1
GSM1061137 0 ductal 6 3 3 48 premenopausal perfect health 28 0 0 3.1 1
GSM1061136 1 ductal 6 3 3 60 postmenopausal perfect health 8 1 0 0.5 1
GSM1061135 0 ductal 6 1 1 56 NA perfect health 12 0 0 -0.6 1
GSM1061134 0 ductal 6 3 2 78 postmenopausal major problems 45 0 1 0.4 1
GSM1061133 1 ductal 6 1 2 43 premenopausal perfect health 12 0 0 -0.7 1
GSM1061132 1 ductal 6 3 2 69 NA perfect health 42 0 2 1.4 1
GSM106113 0 ductal 6 1 2 53 NA perfect health 18 0 0 -0.6 1
GSM1061130 1 lobular 6 1 3 54 postmenopausal perfect health 32 1 0 -0.7 1
GSM1061129 1 ductal 6 1 2 63 NA major problems 35 0 0 -1.1 1
GSM1061128 0 ductal 6 3 3 38 premenopausal perfect health 17 0 0 2.4 0
GSM1061127 1 ductal 6 3 3 70 postmenopausal major problems 45 0 1 1.6 1
GSM1061126 1 lobular 3 1 2 53 postmenopausal minor 8 0 0 -1.2 1
GSM1061125 1 ductal 3 equivocal 2 62 postmenopausal minor 15 0 0 -0.3 1
GSM1061124 1 ductal 3 equivocal 2 58 postmenopausal minor 18 0 1 0.1 1
GSM1061123 1 ductal 3 1 1 51 postmenopausal minor 12 0 0 -1 1
GSM1061122 1 ductal 1 equivocal 2 43 premenopausal minor 13 0 0 -0.1 1
GSM106112 1 lobular 6 1 1 56 postmenopausal minor 20 0 0 -1 1
GSM1061120 0 ductal 6 3 3 45 premenopausal perfect health 13 0 1 1.2 1
GSM1061119 1 ductal 6 1 2 64 postmenopausal major problems 6 0 0 -1.9 1
GSM1061118 0 ductal 6 3 3 87 postmenopausal major problems 45 1 0 1.9 0
GSM1061117 1 ductal 6 1 2 51 NA minor 13 0 1 -0.4 1
GSM1061116 1 lobular 6 1 2 67 postmenopausal minor 30 0 0 -2.3 1
GSM1061115 1 ductal 6 1 1 84 postmenopausal average for age 13 0 0 -0.8 1
GSM1061114 0 ductal 9 3 2 56 postmenopausal perfect health 9 0 0 0.8 0
GSM1061113 0 ductal 9 3 3 47 premenopausal perfect health 33 0 0 3.3 0
GSM1061112 1 ductal 9 1 1 78 postmenopausal perfect health 17 0 0 -0.5 1
GSM106 0 ductal 6 3 3 76 postmenopausal NA 30 1 2 1.6 0
GSM1061110 1 ductal 6 equivocal 2 53 NA major problems 15 0 0 -0.1 1
GSM1061109 1 lobular 6 1 1 52 premenopausal major problems 12 0 0 -2.3 1
GSM1061108 1 ductal 6 1 2 47 NA minor 16 0 0 -1.5 1
GSM1061107 1 ductal 6 3 1 49 premenopausal major problems 15 0 0 1 1
GSM1061106 1 ductal 6 3 2 58 NA perfect health 15 NA 0 0.7 1
GSM1061105 1 ductal 6 3 3 77 postmenopausal minor 22 0 3 1.3 1
GSM1061104 0 ductal 6 equivocal 2 60 postmenopausal minor 9 0 0 0.1 1
GSM1061103 0 ductal 6 3 2 75 postmenopausal average for age 25 0 2 0.9 1
GSM1061102 1 ductal 6 3 3 63 NA minor 18 1 1 0.8 1
GSM106110 1 ductal 6 1 2 66 postmenopausal perfect health 15 0 0 -0.6 1
GSM1061100 0 ductal 6 3 3 49 premenopausal perfect health 15 1 2 0.8 0
GSM1061099 1 ductal 9 3 2 47 premenopausal perfect health 20 0 0 0.4 1
GSM1061098 1 ductal 9 3 2 55 postmenopausal perfect health 17 0 0 2 1
GSM1061097 0 ductal 9 3 2 44 premenopausal perfect health 26 0 0 0.7 1
GSM1061096 1 ductal 9 1 2 64 postmenopausal perfect health 13 0 0 -1 1
GSM1061095 0 ductal 9 3 2 64 postmenopausal perfect health 32 0 1 0.4 1
GSM1061094 1 ductal 9 1 1 49 premenopausal perfect health 21 0 0 -0.6 1
GSM1061093 1 ductal 9 1 2 44 premenopausal perfect health 15 0 0 -0.6 1
GSM1061092 1 ductal 9 3 2 44 premenopausal perfect health 25 0 0 1.1 1
GSM106109 1 lobular 9 1 2 42 premenopausal perfect health 17 0 0 -1.2 1
GSM1061090 0 ductal 9 3 3 31 premenopausal perfect health 23 0 0 2.8 0
GSM1061089 1 ductal 9 equivocal 2 53 premenopausal perfect health 19 0 0 -0.1 1
GSM1061088 0 lobular 9 1 3 82 postmenopausal average for age 27 0 0 -0.3 0
GSM1061087 1 ductal 9 1 1 64 postmenopausal perfect health 12 0 0 -0.8 1
GSM1061086 1 ductal 9 1 2 61 postmenopausal perfect health 15 0 0 -0.4 1
GSM1061085 0 lobular 9 3 3 73 postmenopausal perfect health 22 0 0 0.4 1
GSM1061084 0 ductal 9 3 3 82 postmenopausal average for age 22 1 0 0.4 0
GSM1061083 1 ductal 9 1 2 65 postmenopausal perfect health 11 0 1 -2.2 1
GSM1061082 0 ductal 9 3 3 35 premenopausal perfect health 22 0 1 2.9 1
GSM106108 1 ductal 2 equivocal 2 61 postmenopausal perfect health 25 0 1 -0.1 1
GSM1061080 1 ductal 2 1 1 48 premenopausal minor 10 0 0 -2.5 1
GSM1061079 1 ductal 2 equivocal 2 58 postmenopausal minor 30 0 1 0.2 1
GSM1061078 1 ductal 2 equivocal 2 47 premenopausal minor 17 0 0 -0.1 1
GSM1061077 1 ductal 1 equivocal 3 71 postmenopausal minor 42 0 0 0.1 1
GSM1061076 0 ductal 1 equivocal 2 71 postmenopausal average for age 12 0 0 -0.1 0
GSM1061075 1 ductal 1 3 3 78 postmenopausal average for age 42 1 0 0.6 1
GSM1061074 1 ductal 1 equivocal 2 49 premenopausal minor 15 0 0 -0.2 1
GSM1061073 1 ductal 1 3 3 55 postmenopausal average for age 12 0 0 1.3 1
GSM1061072 1 ductal 1 3 3 73 postmenopausal average for age 40 0 3 1.5 1
GSM106107 1 ductal 1 1 1 42 premenopausal perfect health 41 0 0 -0.8 1
GSM1061070 1 ductal 1 equivocal 1 81 postmenopausal major problems 14 0 0 -0.2 1
GSM1061069 1 ductal 6 equivocal 3 42 premenopausal minor 17 0 0 0.2 1
GSM1061068 1 lobular 6 equivocal 1 78 postmenopausal average for age 19 0 0 -0.3 1
GSM1061067 1 ductal 6 3 3 53 premenopausal perfect health 21 0 1 0.4 1
GSM1061066 0 ductal 9 1 2 50 postmenopausal perfect health 15 1 0 -0.3 1
GSM1061065 0 ductal 9 3 2 39 premenopausal perfect health 13 0 0 2.4 0
GSM1061064 1 lobular 9 equivocal 2 53 postmenopausal perfect health 28 0 3 -0.2 1
GSM1061063 1 ductal 9 3 3 41 premenopausal perfect health 28 0 1 1.5 1
GSM1061062 0 ductal 9 3 3 46 premenopausal perfect health 32 0 0 3.1 0
GSM106106 0 ductal 3 1 1 66 postmenopausal minor 9 0 0 -2 1
GSM1061060 0 ductal 3 3 3 69 postmenopausal major problems 21 0 0 3.1 0
GSM1061059 1 ductal 3 3 2 60 postmenopausal major problems 24 0 0 0.6 1
GSM1061058 1 lobular 3 3 3 54 postmenopausal minor 35 0 0 0.9 1
GSM1061057 1 ductal 3 3 3 71 postmenopausal NA 19 0 0 1.5 1
GSM1061056 1 ductal 3 equivocal 1 76 postmenopausal average for age 24 0 0 -0.2 1
GSM1061055 1 ductal 3 equivocal 1 78 postmenopausal perfect health 18 0 0 -0.3 1
GSM1061054 1 ductal 8 1 3 73 postmenopausal perfect health 44 0 3 -0.6 1
GSM1061053 0 ductal 2 3 3 48 premenopausal minor 11 0 0 1.2 0
GSM1061052 1 ductal 2 equivocal 2 56 postmenopausal minor 16 1 2 0.3 1
GSM106105 1 ductal 2 1 2 77 postmenopausal minor 11 0 1 -1 1
GSM1061050 1 ductal 2 1 2 51 premenopausal minor 28 0 1 -1.5 1
GSM1061049 1 ductal 2 1 1 67 postmenopausal minor 18 0 0 -2.3 1
GSM1061048 1 ductal 2 equivocal 2 48 premenopausal perfect health 10 0 0 0 1
GSM1061047 1 ductal 6 1 3 67 postmenopausal perfect health 18 0 1 -0.4 1
GSM1061046 0 ductal 6 3 2 66 postmenopausal perfect health 50 0 0 0.7 1
GSM1061045 1 ductal 6 1 1 72 postmenopausal minor 11 0 3 -1.8 1
GSM1061044 1 ductal 6 1 2 53 NA perfect health 12 0 0 -1.3 1
GSM1061043 0 ductal 6 3 3 54 postmenopausal minor 45 1 0 1.5 0
GSM1061042 0 ductal 6 3 2 61 postmenopausal perfect health 10 0 0 0.6 1
GSM106104 1 lobular 1 equivocal 2 81 postmenopausal major problems 15 0 0 0.1 1
GSM1061040 1 ductal 1 equivocal 2 47 premenopausal minor 13 0 0 0 1
GSM1061039 0 ductal 1 3 3 90 postmenopausal NA 18 NA 0 0.4 0
GSM1061038 1 lobular 1 1 2 61 postmenopausal minor 11 0 0 -0.8 1
GSM1061037 1 lobular 1 1 1 76 postmenopausal average for age 16 0 0 -2.2 1
GSM1061036 0 ductal 1 3 3 43 NA perfect health 19 0 0 2.5 0
GSM1061035 1 ductal 1 1 2 65 postmenopausal average for age 30 0 0 -0.6 1
GSM1061034 0 ductal 4 3 2 59 postmenopausal average for age 10 1 0 0.5 0
GSM1061033 1 ductal 4 3 2 60 postmenopausal major problems 22 0 0 2.2 1
GSM1061032 1 ductal 6 3 2 68 postmenopausal perfect health 17 0 0 0.7 1

Tags

  • breast
  • breast cancer
  • breast carcinoma
  • cancer
  • carcinoma

Other Formats

JSON    XML
  • About
  • Blog
  • Help
  • FAQ
  • Downloads
  • API
  • iPhone App
  • Email updates
© 2026 The Scripps Research Institute. All rights reserved. (ver 94eefe6 )
  • Terms of Use